ANDA Litigation: Patents are Being Challenged Sooner, OxyContin Draws Most Fire
November 6, 2014
The Pink Sheet
Axinn Partner Chad Landmon was quoted in The Pink Sheet’s article, “ANDA Litigation: Patents are Being Challenged Sooner, OxyContin Draws Most Fire.” The Pink Sheet is produced by Pharma & Med Tech Business Intelligence.
Click here to access the article.